Table of Contents 1 Pertuzumab Market Overview 1.1 Product Overview and Scope of Pertuzumab 1.2 Pertuzumab Segment by Type 1.2.1 Global Pertuzumab Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Human Source 1.2.3 Animal Source 1.3 Pertuzumab Segment by Application 1.3.1 Pertuzumab Sales Comparison by Application: 2020 VS 2026 1.3.2 Hospital 1.3.3 Medical Center 1.4 Global Pertuzumab Market Size Estimates and Forecasts 1.4.1 Global Pertuzumab Revenue 2015-2026 1.4.2 Global Pertuzumab Sales 2015-2026 1.4.3 Pertuzumab Market Size by Region: 2020 Versus 2026 2 Global Pertuzumab Market Competition by Manufacturers 2.1 Global Pertuzumab Sales Market Share by Manufacturers (2015-2020) 2.2 Global Pertuzumab Revenue Share by Manufacturers (2015-2020) 2.3 Global Pertuzumab Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Pertuzumab Manufacturing Sites, Area Served, Product Type 2.5 Pertuzumab Market Competitive Situation and Trends 2.5.1 Pertuzumab Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Pertuzumab Players (Opinion Leaders) 3 Pertuzumab Retrospective Market Scenario by Region 3.1 Global Pertuzumab Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Pertuzumab Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Pertuzumab Market Facts & Figures by Country 3.3.1 North America Pertuzumab Sales by Country 3.3.2 North America Pertuzumab Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Pertuzumab Market Facts & Figures by Country 3.4.1 Europe Pertuzumab Sales by Country 3.4.2 Europe Pertuzumab Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Pertuzumab Market Facts & Figures by Region 3.5.1 Asia Pacific Pertuzumab Sales by Region 3.5.2 Asia Pacific Pertuzumab Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Pertuzumab Market Facts & Figures by Country 3.6.1 Latin America Pertuzumab Sales by Country 3.6.2 Latin America Pertuzumab Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Pertuzumab Market Facts & Figures by Country 3.7.1 Middle East and Africa Pertuzumab Sales by Country 3.7.2 Middle East and Africa Pertuzumab Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Pertuzumab Historic Market Analysis by Type 4.1 Global Pertuzumab Sales Market Share by Type (2015-2020) 4.2 Global Pertuzumab Revenue Market Share by Type (2015-2020) 4.3 Global Pertuzumab Price Market Share by Type (2015-2020) 4.4 Global Pertuzumab Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Pertuzumab Historic Market Analysis by Application 5.1 Global Pertuzumab Sales Market Share by Application (2015-2020) 5.2 Global Pertuzumab Revenue Market Share by Application (2015-2020) 5.3 Global Pertuzumab Price by Application (2015-2020) 6 Company Profiles and Key Figures in Pertuzumab Business 6.1 Novartis AG 6.1.1 Corporation Information 6.1.2 Novartis AG Description, Business Overview and Total Revenue 6.1.3 Novartis AG Pertuzumab Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Novartis AG Products Offered 6.1.5 Novartis AG Recent Development 6.2 Pfizer 6.2.1 Pfizer Pertuzumab Production Sites and Area Served 6.2.2 Pfizer Description, Business Overview and Total Revenue 6.2.3 Pfizer Pertuzumab Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Pfizer Products Offered 6.2.5 Pfizer Recent Development 6.3 Abnova Corporation 6.3.1 Abnova Corporation Pertuzumab Production Sites and Area Served 6.3.2 Abnova Corporation Description, Business Overview and Total Revenue 6.3.3 Abnova Corporation Pertuzumab Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Abnova Corporation Products Offered 6.3.5 Abnova Corporation Recent Development 6.4 InvivoGen 6.4.1 InvivoGen Pertuzumab Production Sites and Area Served 6.4.2 InvivoGen Description, Business Overview and Total Revenue 6.4.3 InvivoGen Pertuzumab Sales, Revenue and Gross Margin (2015-2020) 6.4.4 InvivoGen Products Offered 6.4.5 InvivoGen Recent Development 6.5 Celltrion 6.5.1 Celltrion Pertuzumab Production Sites and Area Served 6.5.2 Celltrion Description, Business Overview and Total Revenue 6.5.3 Celltrion Pertuzumab Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Celltrion Products Offered 6.5.5 Celltrion Recent Development 6.6 Biocon Limited 6.6.1 Biocon Limited Pertuzumab Production Sites and Area Served 6.6.2 Biocon Limited Description, Business Overview and Total Revenue 6.6.3 Biocon Limited Pertuzumab Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Biocon Limited Products Offered 6.6.5 Biocon Limited Recent Development 6.7 Bio-Techne 6.6.1 Bio-Techne Pertuzumab Production Sites and Area Served 6.6.2 Bio-Techne Description, Business Overview and Total Revenue 6.6.3 Bio-Techne Pertuzumab Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Bio-Techne Products Offered 6.7.5 Bio-Techne Recent Development 7 Pertuzumab Manufacturing Cost Analysis 7.1 Pertuzumab Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Pertuzumab 7.4 Pertuzumab Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Pertuzumab Distributors List 8.3 Pertuzumab Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Pertuzumab Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Pertuzumab by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Pertuzumab by Type (2021-2026) 10.2 Pertuzumab Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Pertuzumab by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Pertuzumab by Application (2021-2026) 10.3 Pertuzumab Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Pertuzumab by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Pertuzumab by Region (2021-2026) 10.4 North America Pertuzumab Estimates and Projections (2021-2026) 10.5 Europe Pertuzumab Estimates and Projections (2021-2026) 10.6 Asia Pacific Pertuzumab Estimates and Projections (2021-2026) 10.7 Latin America Pertuzumab Estimates and Projections (2021-2026) 10.8 Middle East and Africa Pertuzumab Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Pertuzumab Sales (K MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global Pertuzumab Sales (K MT) Comparison by Application: 2020 VS 2026 Table 3. Global Pertuzumab Market Size by Type (K MT) (US$ Million) (2020 VS 2026) Table 4. Global Key Pertuzumab Manufacturers Covered in This Study Table 5. Global Pertuzumab Sales (K MT) by Manufacturers (2015-2020) Table 6. Global Pertuzumab Sales Share by Manufacturers (2015-2020) Table 7. Global Pertuzumab Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Pertuzumab Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Pertuzumab Average Price (USD/MT) of Key Manufacturers (2015-2020) Table 10. Manufacturers Pertuzumab Sales Sites and Area Served Table 11. Manufacturers Pertuzumab Product Types Table 12. Global Pertuzumab Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Pertuzumab by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pertuzumab as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Pertuzumab Players Table 16. Global Pertuzumab Sales (K MT) by Region (2015-2020) Table 17. Global Pertuzumab Sales Market Share by Region (2015-2020) Table 18. Global Pertuzumab Revenue (Million US$) by Region (2015-2020) Table 19. Global Pertuzumab Revenue Market Share by Region (2015-2020) Table 20. North America Pertuzumab Sales by Country (2015-2020) (K MT) Table 21. North America Pertuzumab Sales Market Share by Country (2015-2020) Table 22. North America Pertuzumab Revenue by Country (2015-2020) (US$ Million) Table 23. North America Pertuzumab Revenue Market Share by Country (2015-2020) Table 24. Europe Pertuzumab Sales by Country (2015-2020) (K MT) Table 25. Europe Pertuzumab Sales Market Share by Country (2015-2020) Table 26. Europe Pertuzumab Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Pertuzumab Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Pertuzumab Sales by Region (2015-2020) (K MT) Table 29. Asia Pacific Pertuzumab Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Pertuzumab Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Pertuzumab Revenue Market Share by Region (2015-2020) Table 32. Latin America Pertuzumab Sales by Country (2015-2020) (K MT) Table 33. Latin America Pertuzumab Sales Market Share by Country (2015-2020) Table 34. Latin America Pertuzumab Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Pertuzumab Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Pertuzumab Sales by Country (2015-2020) (K MT) Table 37. Middle East and Africa Pertuzumab Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Pertuzumab Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Pertuzumab Revenue Market Share by Country (2015-2020) Table 40. Global Pertuzumab Sales (K MT) by Type (2015-2020) Table 41. Global Pertuzumab Sales Share by Type (2015-2020) Table 42. Global Pertuzumab Revenue (Million US$) by Type (2015-2020) Table 43. Global Pertuzumab Revenue Share by Type (2015-2020) Table 44. Global Pertuzumab Price (USD/MT) by Type (2015-2020) Table 45. Global Pertuzumab Sales (K MT) by Application (2015-2020) Table 46. Global Pertuzumab Sales Market Share by Application (2015-2020) Table 47. Global Pertuzumab Sales Growth Rate by Application (2015-2020) Table 48. Novartis AG Pertuzumab Corporation Information Table 49. Novartis AG Description and Business Overview Table 50. Novartis AG Pertuzumab Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 51. Novartis AG Main Product Table 52. Novartis AG Recent Development Table 53. Pfizer Pertuzumab Corporation Information Table 54. Pfizer Corporation Information Table 55. Pfizer Pertuzumab Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 56. Pfizer Main Product Table 57. Pfizer Recent Development Table 58. Abnova Corporation Pertuzumab Corporation Information Table 59. Abnova Corporation Corporation Information Table 60. Abnova Corporation Pertuzumab Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 61. Abnova Corporation Main Product Table 62. Abnova Corporation Recent Development Table 63. InvivoGen Pertuzumab Corporation Information Table 64. InvivoGen Corporation Information Table 65. InvivoGen Pertuzumab Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 66. InvivoGen Main Product Table 67. InvivoGen Recent Development Table 68. Celltrion Pertuzumab Corporation Information Table 69. Celltrion Corporation Information Table 70. Celltrion Pertuzumab Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 71. Celltrion Main Product Table 72. Celltrion Recent Development Table 73. Biocon Limited Pertuzumab Corporation Information Table 74. Biocon Limited Corporation Information Table 75. Biocon Limited Pertuzumab Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 76. Biocon Limited Main Product Table 77. Biocon Limited Recent Development Table 78. Bio-Techne Pertuzumab Corporation Information Table 79. Bio-Techne Corporation Information Table 80. Bio-Techne Pertuzumab Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 81. Bio-Techne Main Product Table 82. Bio-Techne Recent Development Table 83. Sales Base and Market Concentration Rate of Raw Material Table 84. Key Suppliers of Raw Materials Table 85. Pertuzumab Distributors List Table 86. Pertuzumab Customers List Table 87. Market Key Trends Table 88. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 89. Key Challenges Table 90. Global Pertuzumab Sales (K MT) Forecast by Type (2021-2026) Table 91. Global Pertuzumab Sales Market Share Forecast by Type (2021-2026) Table 92. Global Pertuzumab Revenue (Million US$) Forecast by Type (2021-2026) Table 93. Global Pertuzumab Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 94. Global Pertuzumab Sales (K MT) Forecast by Application (2021-2026) Table 95. Global Pertuzumab Revenue (Million US$) Forecast by Application (2021-2026) Table 96. Global Pertuzumab Sales (K MT) Forecast by Region (2021-2026) Table 97. Global Pertuzumab Sales Market Share Forecast by Region (2021-2026) Table 98. Global Pertuzumab Revenue Forecast by Region (2021-2026) (US$ Million) Table 99. Global Pertuzumab Revenue Market Share Forecast by Region (2021-2026) Table 100. Research Programs/Design for This Report Table 101. Key Data Information from Secondary Sources Table 102. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Pertuzumab Figure 2. Global Pertuzumab Sales Market Share by Type: 2020 VS 2026 Figure 3. Human Source Product Picture Figure 4. Animal Source Product Picture Figure 5. Global Pertuzumab Consumption Market Share by Application: 2020 VS 2026 Figure 6. Hospital Figure 7. Medical Center Figure 8. Global Pertuzumab Market Size 2015-2026 (US$ Million) Figure 9. Global Pertuzumab Sales Capacity (K MT) (2015-2026) Figure 10. Global Pertuzumab Market Size Market Share by Region: 2020 Versus 2026 Figure 11. Pertuzumab Sales Share by Manufacturers in 2020 Figure 12. Global Pertuzumab Revenue Share by Manufacturers in 2019 Figure 13. The Global 5 and 10 Largest Players: Market Share by Pertuzumab Revenue in 2019 Figure 14. Pertuzumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 15. Global Pertuzumab Sales Market Share by Region (2015-2020) Figure 16. Global Pertuzumab Sales Market Share by Region in 2019 Figure 17. Global Pertuzumab Revenue Market Share by Region (2015-2020) Figure 18. Global Pertuzumab Revenue Market Share by Region in 2019 Figure 19. North America Pertuzumab Sales Market Share by Country in 2019 Figure 20. North America Pertuzumab Revenue Market Share by Country in 2019 Figure 21. U.S. Pertuzumab Sales Growth Rate (2015-2020) (K MT) Figure 22. U.S. Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million) Figure 23. Canada Pertuzumab Sales Growth Rate (2015-2020) (K MT) Figure 24. Canada Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Europe Pertuzumab Sales Market Share by Country in 2019 Figure 26. Europe Pertuzumab Revenue Market Share by Country in 2019 Figure 27. Germany Pertuzumab Sales Growth Rate (2015-2020) (K MT) Figure 28. Germany Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. France Pertuzumab Sales Growth Rate (2015-2020) (K MT) Figure 30. France Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. U.K. Pertuzumab Sales Growth Rate (2015-2020) (K MT) Figure 32. U.K. Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. Italy Pertuzumab Sales Growth Rate (2015-2020) (K MT) Figure 34. Italy Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Russia Pertuzumab Sales Growth Rate (2015-2020) (K MT) Figure 36. Russia Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Asia Pacific Pertuzumab Sales Market Share by Region in 2019 Figure 38. Asia Pacific Pertuzumab Revenue Market Share by Region in 2019 Figure 39. China Pertuzumab Sales Growth Rate (2015-2020) (K MT) Figure 40. China Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Japan Pertuzumab Sales Growth Rate (2015-2020) (K MT) Figure 42. Japan Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. South Korea Pertuzumab Sales Growth Rate (2015-2020) (K MT) Figure 44. South Korea Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. India Pertuzumab Sales Growth Rate (2015-2020) (K MT) Figure 46. India Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. Australia Pertuzumab Sales Growth Rate (2015-2020) (K MT) Figure 48. Australia Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Taiwan Pertuzumab Sales Growth Rate (2015-2020) (K MT) Figure 50. Taiwan Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Indonesia Pertuzumab Sales Growth Rate (2015-2020) (K MT) Figure 52. Indonesia Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Thailand Pertuzumab Sales Growth Rate (2015-2020) (K MT) Figure 54. Thailand Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Malaysia Pertuzumab Sales Growth Rate (2015-2020) (K MT) Figure 56. Malaysia Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Philippines Pertuzumab Sales Growth Rate (2015-2020) (K MT) Figure 58. Philippines Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Vietnam Pertuzumab Sales Growth Rate (2015-2020) (K MT) Figure 60. Vietnam Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Latin America Pertuzumab Sales Market Share by Country in 2019 Figure 62. Latin America Pertuzumab Revenue Market Share by Country in 2019 Figure 63. Mexico Pertuzumab Sales Growth Rate (2015-2020) (K MT) Figure 64. Mexico Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Brazil Pertuzumab Sales Growth Rate (2015-2020) (K MT) Figure 66. Brazil Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Argentina Pertuzumab Sales Growth Rate (2015-2020) (K MT) Figure 68. Argentina Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Middle East and Africa Pertuzumab Sales Market Share by Country in 2019 Figure 70. Middle East and Africa Pertuzumab Revenue Market Share by Country in 2019 Figure 71. Turkey Pertuzumab Sales Growth Rate (2015-2020) (K MT) Figure 72. Turkey Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Saudi Arabia Pertuzumab Sales Growth Rate (2015-2020) (K MT) Figure 74. Saudi Arabia Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. U.A.E Pertuzumab Sales Growth Rate (2015-2020) (K MT) Figure 76. U.A.E Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Sales Market Share of Pertuzumab by Type (2015-2020) Figure 78. Sales Market Share of Pertuzumab by Type in 2019 Figure 79. Revenue Share of Pertuzumab by Type (2015-2020) Figure 80. Revenue Market Share of Pertuzumab by Type in 2019 Figure 81. Global Pertuzumab Sales Growth by Type (2015-2020) (K MT) Figure 82. Global Pertuzumab Sales Market Share by Application (2015-2020) Figure 83. Global Pertuzumab Sales Market Share by Application in 2019 Figure 84. Global Revenue Share of Pertuzumab by Application (2015-2020) Figure 85. Global Revenue Share of Pertuzumab by Application in 2020 Figure 86. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 87. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. Abnova Corporation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. InvivoGen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Celltrion Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Biocon Limited Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Bio-Techne Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Price Trend of Key Raw Materials Figure 94. Manufacturing Cost Structure of Pertuzumab Figure 95. Manufacturing Process Analysis of Pertuzumab Figure 96. Pertuzumab Industrial Chain Analysis Figure 97. Channels of Distribution Figure 98. Distributors Profiles Figure 99. Porter's Five Forces Analysis Figure 100. North America Pertuzumab Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 101. North America Pertuzumab Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 102. Europe Pertuzumab Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 103. Europe Pertuzumab Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 104. Latin America Pertuzumab Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 105. Latin America Pertuzumab Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 106. Middle East and Africa Pertuzumab Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 107. Middle East and Africa Pertuzumab Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 108. Asia Pacific Pertuzumab Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 109. Asia Pacific Pertuzumab Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 110. Bottom-up and Top-down Approaches for This Report Figure 111. Data Triangulation Figure 112. Key Executives Interviewed

Novartis AG Pfizer Abnova Corporation InvivoGen Celltrion Biocon Limited Bio-Techne